<DOC>
	<DOCNO>NCT01798147</DOCNO>
	<brief_summary>Selective Internal Radiotherapy superior Transarterial Chemoembolisation treatment intrahepatic cholangiocellular carcinoma ( CCC ) .</brief_summary>
	<brief_title>Selective Internal Radiotherapy ( SIRT ) Versus Transarterial Chemoembolisation ( TACE ) Treatment Cholangiocellular Carcinoma ( CCC ) .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<criteria>≥18 year Intrahepatic CCC , proven histology typical morphology cross sectional imaging elevate tumor marker ( CEA CA 199 ) Tumor confine liver At least one measurable lesion magnetic resonance imaging ( MRI ) Tumor load ≤ 50 % Preserved liver function ( Child Pugh A B ) ECOG performance status ≤2 Patients feasible curative treatment ( e.g . resection local ablation ) Previous TACE SIRT Prior Chemotherapy Child Pugh stage C ECOG Performance Status &gt; 1 Tumor involvement &gt; 50 % liver Extrahepatic tumor Serum Bilirubin &gt; 2.0 mg/dl ; Serum Albumin 2.8 g/dl , Serum Creatinine &gt; 2 mg/dl ; Leukocytes &lt; 3000/ml ; Thrombocytes &lt; 50000/ml Clinically apparent ascites ( ascites CT/MRI exclusion criterion ) Esophageal bleed last 3 month Hepatic encephalopathy Transjugular intrahepatic portosystemic shunt ( TIPS ) Infiltration occlusion main portal vein Hepatofugal blood flow portal vein Hepatopulmonary shunt ≥ 20 % macroaggregated albumin scan ( MAAscan ) Contraindications angiography Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Cholangiocellular Carcinoma</keyword>
	<keyword>TACE</keyword>
	<keyword>SIRT</keyword>
</DOC>